Match tier
Listed
Presence
Current · Arkansas
Last published
2024
Sources
OpenAlex · ORCID
Refreshed
2026-10-03
E
Ebony Cotton
Role not yet determined Is this you? Add your title
Also affiliated: United States Food and Drug Administration (2020–2024); University of Tennessee Health Science Center (2020)
2 h-index
6 pubs
28 cited
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Ebony Cotton's research has focused on the intersection of pharmacology, toxicology, and molecular biology. Her work has investigated the molecular mechanisms underlying the effects of various compounds, including the antineoplastic agent vorinostat. Cotton has examined gene expression regulation in neoplastic cells, with attention to receptors such as the progesterone receptor and estrogen receptor alpha, as well as oncogenes like Erb-b2. Her research has utilized human tumor cell lines to study these cellular processes. Cotton has published five papers, accumulating 23 citations, and holds an h-index of 1. She has collaborated with researchers Yifan Zhang, Leihong Wu, and Joshua Xu, all from the National Center for Toxicological Research, on shared publications.
Metrics
- h-index: 2
- Publications: 6
- Citations: 28
Selected Publications
-
Enhancing pharmacogenomic data accessibility and drug safety with large language models: a case study with Llama3.1 (2024)
-
Abstract B125: Molecular profiling basal 2 subtypes of triple-negative breast cancer cells and their response to histone deacetylase inhibitor (2020)
-
Modulation of Estrogen α and Progesterone Receptors in Triple Negative Breast Cancer Cell Lines: The Effects of Vorinostat and Indole-3-Carbinol In Vitro (2020)
-
Abstract 5196: Vorinostat exhibits anticancer effects through modulation of nuclear receptors and tumor suppressor genes in sub-types of triple negative breast cancer cells (2019)
Collaboration Network
Top Collaborators
Beverly Word
National Center for Toxicological Research
3 shared publications
In database
- Modulation of Estrogen α and Progesterone Receptors in Triple Negative Breast Cancer Cell Lines: The Effects of Vorinostat and Indole-3-Carbinol In Vitro
- Abstract B125: Molecular profiling basal 2 subtypes of triple-negative breast cancer cells and their response to histone deacetylase inhibitor
- Abstract 5196: Vorinostat exhibits anticancer effects through modulation of nuclear receptors and tumor suppressor genes in sub-types of triple negative breast cancer cells
Beverly Lyn‐Cook
National Center for Toxicological Research
3 shared publications
In database
- Modulation of Estrogen α and Progesterone Receptors in Triple Negative Breast Cancer Cell Lines: The Effects of Vorinostat and Indole-3-Carbinol In Vitro
- Abstract B125: Molecular profiling basal 2 subtypes of triple-negative breast cancer cells and their response to histone deacetylase inhibitor
- Abstract 5196: Vorinostat exhibits anticancer effects through modulation of nuclear receptors and tumor suppressor genes in sub-types of triple negative breast cancer cells
Kai Littlejohn
National Center for Toxicological Research
2 shared publications
In database
- Modulation of Estrogen α and Progesterone Receptors in Triple Negative Breast Cancer Cell Lines: The Effects of Vorinostat and Indole-3-Carbinol In Vitro
- Abstract 5196: Vorinostat exhibits anticancer effects through modulation of nuclear receptors and tumor suppressor genes in sub-types of triple negative breast cancer cells
Fatemeh NouriEmamzaden
National Center for Toxicological Research
1 shared publication
In database
- Modulation of Estrogen α and Progesterone Receptors in Triple Negative Breast Cancer Cell Lines: The Effects of Vorinostat and Indole-3-Carbinol In Vitro
A Hawkins
National Center for Toxicological Research
1 shared publication
In database
- Modulation of Estrogen α and Progesterone Receptors in Triple Negative Breast Cancer Cell Lines: The Effects of Vorinostat and Indole-3-Carbinol In Vitro
Rhonda J. Moore
Center for Drug Evaluation and Research (US)
1 shared publication
- Modulation of Estrogen α and Progesterone Receptors in Triple Negative Breast Cancer Cell Lines: The Effects of Vorinostat and Indole-3-Carbinol In Vitro
GUSTAV MIRANDA-CARBON
University of Tennessee Health Science Center (US)
1 shared publication
- Modulation of Estrogen α and Progesterone Receptors in Triple Negative Breast Cancer Cell Lines: The Effects of Vorinostat and Indole-3-Carbinol In Vitro
Chinna N. Orish
University of Port Harcourt (NG)
1 shared publication
- Modulation of Estrogen α and Progesterone Receptors in Triple Negative Breast Cancer Cell Lines: The Effects of Vorinostat and Indole-3-Carbinol In Vitro
Destiny Stovall
University of Arkansas at Pine Bluff
1 shared publication
In database
- Abstract B125: Molecular profiling basal 2 subtypes of triple-negative breast cancer cells and their response to histone deacetylase inhibitor
George Hammons
National Center for Toxicological Research
1 shared publication
In database
- Abstract B125: Molecular profiling basal 2 subtypes of triple-negative breast cancer cells and their response to histone deacetylase inhibitor
Fatemeh NouriEmamzadeh
National Center for Toxicological Research
1 shared publication
In database
- Abstract 5196: Vorinostat exhibits anticancer effects through modulation of nuclear receptors and tumor suppressor genes in sub-types of triple negative breast cancer cells
Gustavo A. Miranda‐Carboni
University of Tennessee Health Science Center (US)
1 shared publication
- Abstract 5196: Vorinostat exhibits anticancer effects through modulation of nuclear receptors and tumor suppressor genes in sub-types of triple negative breast cancer cells
Dan Li
National Center for Toxicological Research (US)
1 shared publication
- Enhancing pharmacogenomic data accessibility and drug safety with large language models: a case study with Llama3.1
Leihong Wu
National Center for Toxicological Research
1 shared publication
In database
- Enhancing pharmacogenomic data accessibility and drug safety with large language models: a case study with Llama3.1
Ying-Chi Lin
Kaohsiung Medical University (TW)
1 shared publication
- Enhancing pharmacogenomic data accessibility and drug safety with large language models: a case study with Llama3.1
Similar Researchers
Based on overlapping research topics
Luke Enemark
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Cancer-related molecular mechanisms research
Receptor Mechanisms and Signaling
Kyounghyun Kim
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Cancer-related molecular mechanisms research
Receptor Mechanisms and Signaling
Ana Clara P. Azevedo‐Pouly
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Cancer-related molecular mechanisms research
Receptor Mechanisms and Signaling
Trent R. Percy
University of Arkansas – Fort Smith
Cancer-related molecular mechanisms research
Receptor Mechanisms and Signaling
Gene expression and cancer classification
Dane Richey
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Receptor Mechanisms and Signaling
Medical Research
Lirit N. Franks
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Cancer-related molecular mechanisms research
Receptor Mechanisms and Signaling